Umfang:
1 Online-Ressource (IX, 227 Seiten) :
,
Illustrationen, Diagramme.
ISBN:
978-3-318-01261-3
Serie:
Frontiers of hormone research Vol. 33
Inhalt:
It has been known for over 40 years that GH-deficient children benefit from replacement with the hormone. But GH, essential for longitudinal growth, also plays a role after completion of final height. With the introduction of biosynthetic human GH 20 years ago, the use of GH was no longer restricted to severe growth retardation in hypopituitary children.This book will take the reader behind the myths of GH and into the real world of clinical endocrinology. The contributions stem from recognized clinicians and scientists who have been working in the field for decades. The contents encompass traditional end points of GH therapy such as body composition, bone biology and physical performance. Attention is also devoted to diagnostic aspects and side effects. Additional features range from clinical epidemiology to quality of life, and novel areas such as the impact of traumatic brain injury on pituitary function are also covered. The present volume of 〈i〉Frontiers of Hormone Research〈/i〉 is essential reading for health care professionals interested in clinical endocrinology and GH.
Anmerkung:
from clinical and biochemical features to risks and benefits of GH treatment
Weitere Ausg.:
Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-7992-6
Sprache:
Englisch
Fachgebiete:
Medizin
Schlagwort(e):
Minderwuchs
;
Erwachsener
;
Somatotropin
;
Aufsatzsammlung
DOI:
10.1159/isbn.978-3-318-01261-3
